- ISIN
- US92332W1053
- CUSIP
- 92332W105
- Sector
- Healthcare
- Industry
- Medical Devices
- IPO Date
- Nov 5, 2012
Highlights
- Market Cap
- $577.24K
- Enterprise Value
- $53.63M
- EPS (TTM)
- -$32.92
- Total Revenue (TTM)
- $58.88M
- Gross Profit (TTM)
- $37.89M
- EBITDA (TTM)
- -$45.42M
- Year Range
- $0.25 - $12.93
- ROA (TTM)
- -88.62%
- ROE (TTM)
- -2,043.17%
Share Price Chart
Loading charts...
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Performance
VERO Performance Chart
Venus Concept Inc. (VERO) is down 79.0% since the beginning of the year. At $0 per share, VERO is trading 97.6% below its 52-week high of $13. Investors who bought $1,000 worth of VERO shares 5 years ago would now be looking at an investment worth $1.
Loading charts...
Returns By Period
Venus Concept Inc. (VERO) has returned -79.02% so far this year and -86.95% over the past 12 months. Over the last ten years, VERO has returned -30.82% per year, falling short of the S&P 500 Index benchmark, which averaged 13.66% annually.
Venus Concept Inc.
- 1D
- 0.00%
- 1M
- 0.00%
- YTD
- -79.02%
- 6M
- -82.84%
- 1Y
- -86.95%
- 3Y*
- -76.34%
- 5Y*
- -75.83%
- 10Y*
- -30.82%
Benchmark (S&P 500 Index)
- 1D
- -0.74%
- 1M
- 4.90%
- YTD
- 10.35%
- 6M
- 10.28%
- 1Y
- 26.52%
- 3Y*
- 20.83%
- 5Y*
- 12.30%
- 10Y*
- 13.66%
VERO Monthly Returns History
Based on dividend-adjusted daily data since Nov 5, 2012, VERO's average daily return is +58.14%, while the average monthly return is +868.99%. At this rate, an investment would double in approximately 0.0 years.
Historically, 30% of months were positive and 70% were negative. The best month was Oct 2017 with a return of +143,500.0%, while the worst month was Jul 2013 at -85.4%. The longest winning streak lasted 3 consecutive months, and the longest losing streak was 7 months.
On a daily basis, VERO closed higher 30% of trading days. The best single day was Oct 12, 2017 with a return of +198,300.0%, while the worst single day was Dec 29, 2014 at -61.1%.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | -14.19% | -75.59% | 13.98% | -12.12% | 0.00% | 0.00% | -79.02% | ||||||
| 2025 | -10.76% | -9.11% | -16.95% | -12.90% | 0.00% | -2.47% | 6.33% | -12.30% | 4.07% | -6.96% | -7.48% | -25.25% | -64.26% |
| 2024 | 5.93% | -32.00% | -18.71% | -4.57% | -19.63% | 47.64% | -10.50% | -22.89% | 13.04% | -32.83% | -21.71% | 17.29% | -68.09% |
| 2023 | 11.87% | -36.79% | -3.14% | -13.87% | -23.38% | -3.23% | -10.48% | -10.11% | 15.98% | 0.00% | -22.45% | -22.37% | -75.42% |
| 2022 | -7.06% | 4.43% | -13.33% | -41.68% | -11.85% | -36.92% | 24.95% | -46.73% | 42.53% | -47.73% | 4.30% | 33.39% | -81.18% |
| 2021 | 9.83% | 36.84% | -9.62% | -19.15% | 7.37% | 52.45% | -25.72% | -1.30% | 10.09% | -24.30% | -32.63% | 32.81% | -1.73% |
Benchmark Metrics
Venus Concept Inc. has an annualized alpha of 34430976039291321149880355429563164801983187068649472.00%, beta of -9.97, and R2 of 0.00 versus S&P 500 Index. Calculated based on daily prices since November 06, 2012.
- This stock participated in 242.11% of S&P 500 Index downside but only -47.68% of its upside - more exposed to losses than it benefited from rallies.
- Beta of -9.97 may look defensive, but with R2 of 0.00 this stock is largely uncorrelated with S&P 500 Index - low beta reflects independence, not downside protection. See the Volatility section for a true picture of this stock's risk.
- R2 of 0.00 means this stock moves largely independently of S&P 500 Index - capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.
- Alpha
- 34,430,976,039,291,320,000,000,000,000,000,000,000,000,000,000,000,000.00%
- Beta
- -9.97
- R²
- 0.00
- Upside Capture
- -47.68%
- Downside Capture
- 242.11%
Return for Risk
Risk / Return Rank
VERO ranks 39 for risk / return — below 39% of stocks on our site. The returns aren't fully compensating for the risk involved. This isn't necessarily a dealbreaker, but factor it into your decision — especially if you're risk-averse.
Return / Risk — by metrics
The table below present risk-adjusted performance metrics for Venus Concept Inc. (VERO) and compare them to S&P 500 Index.
| VERO | Benchmark | Difference | |
|---|---|---|---|
Sharpe ratioReturn per unit of total volatility | -0.18 | 2.24 | -2.42 |
Sortino ratioReturn per unit of downside risk | 1.71 | 3.07 | -1.36 |
Omega ratioGain probability vs. loss probability | 1.28 | 1.41 | -0.13 |
Calmar ratioReturn relative to maximum drawdown | -0.90 | 2.93 | -3.83 |
Martin ratioReturn relative to average drawdown | -1.39 | 13.52 | -14.91 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Dividends
Dividend History
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.
Loading charts...
Worst Drawdowns
The table below displays the maximum drawdowns of the Venus Concept Inc.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the Venus Concept Inc. was 100.00%, occurring on Apr 1, 2026. The portfolio has not yet recovered.
The current Venus Concept Inc. drawdown is 100.00%.
Related event | Drawdown | Fall | Recovery | Underwater |
|---|---|---|---|---|
2026 bear market2026 | -100.00%Apr 2026 | 8y 5mo | — | 8y 7moOct 2017 - now |
2015 bear market2015 | -99.92%Sep 2015 | 2y 9mo | 2y 1mo | 4y 11moNov 2012 - Oct 2017 |
Drawdown Indicators
| VERO | Benchmark | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -100.00% | -56.78% | -43.22% |
Max Drawdown (1Y)Largest decline over 1 year | -96.24% | -9.10% | -87.14% |
Max Drawdown (3Y)Largest decline over 3 years | -98.93% | -18.90% | -80.03% |
Max Drawdown (5Y)Largest decline over 5 years | -99.94% | -25.43% | -74.51% |
Max Drawdown (10Y)Largest decline over 10 years | -100.00% | -33.92% | -66.08% |
Current DrawdownCurrent decline from peak | -100.00% | -0.74% | -99.26% |
Average DrawdownAverage peak-to-trough decline | -94.60% | -10.72% | -83.88% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 62.52% | 1.97% | +60.55% |
Volatility
Volatility Chart
The chart below shows the rolling one-month volatility.
Loading charts...
Financials
Financial Performance
The chart below illustrates the trends in the financial health of Venus Concept Inc. over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.
Valuation
The Valuation section provides an overview of how Venus Concept Inc. is priced in the market compared to other companies in the Medical Devices industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.
PS Ratio
This chart shows the Price-to-Sales (P/S) ratio for VERO relative to other companies in the Medical Devices industry. Currently, VERO has a P/S ratio of 0.0. This P/S ratio is low compared to the industry average. It may indicate that the stock is undervalued relative to its revenue, or that the market expects slower growth or lower margins.
PB Ratio
The chart illustrates the Price-to-Book (P/B) ratio for VERO in comparison with other companies in the Medical Devices industry. Currently, VERO has a P/B value of 0.2. This P/B ratio is low compared to industry peers. It might indicate the stock is undervalued or that the company’s assets are not expected to generate strong returns.
Income Statement
| TTM | |
|---|---|
Revenue | — |
Total Revenue | — |
Cost Of Revenue | — |
Gross Profit | — |
Operating Expenses | — |
Selling, General & Admin Expenses | — |
R&D Expenses | — |
Depreciation And Amortization | — |
Total Operating Expenses | — |
Income | — |
Income Before Tax | — |
Operating Income | — |
EBITDA | — |
EBIT | — |
Earnings From Continuing Operations | — |
Net Income | — |
Income Tax Expense | — |
Other Non-Operating Income (Expenses) | — |
Extraordinary Items | — |
Discontinued Operations | — |
Effect Of Accounting Charges | — |
Non Recurring | — |
Minority Interest | — |
Other Items | — |
Interest Income | — |
Interest Expense | — |
Net Interest Income | — |
Build a portfolio with VERO
Add Venus Concept Inc. to a portfolio and analyze allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Analyzer with VERO